Roger Sun is a Managing Director of Matrix China. He joined Matrix China in 2016. Roger has led the investment in JYSS Bio, Naxions, Genecast, Yaoyanshe, Grit Bio, ExCell Bio, etc.
Prior to Matrix China, Roger had 3 years of experience in healthcare investments, and before that, he worked in Deloitte Shanghai and interned at Roche and CFDA, respectively .
Roger graduated from Fudan University with a Bachelor of Pharmacy.